Patents Assigned to Immunai Inc.
  • System for predicting treatment outcomes based upon genetic imputation
    Patent number: 11437148
    Abstract: Methods, systems, and software provide machine learning and artificial intelligence including deep neural networks that enable the creation and operation of unique, AI-driven genomic test results augmentation through variable genetic imputation.
    Type: Grant
    Filed: August 20, 2020
    Date of Patent: September 6, 2022
    Assignee: Immunai Inc.
    Inventors: Noam Solomon, Luis Voloch